Cargando…
Targeted delivery of ZNF416 siRNA-loaded liposomes attenuates experimental pulmonary fibrosis
BACKGROUND: Pulmonary fibrosis is a chronic progressive fibrotic interstitial lung disease characterized by excessive extracellular matrix (ECM) deposition caused by activated fibroblasts. Increasing evidence shows that matrix stiffness is essential in promoting fibroblast activation and profibrotic...
Autores principales: | Cheng, Demin, Li, Ziwei, Wang, Yue, Xiong, Haojie, Sun, Wenqing, Zhou, Siyun, Liu, Yi, Ni, Chunhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652794/ https://www.ncbi.nlm.nih.gov/pubmed/36371191 http://dx.doi.org/10.1186/s12967-022-03740-w |
Ejemplares similares
-
Liposomal UHRF1 siRNA shows lung fibrosis treatment potential through regulation of fibroblast activation
por: Cheng, Demin, et al.
Publicado: (2022) -
ZNF416 is a pivotal transcriptional regulator of fibroblast mechanoactivation
por: Jones, Dakota L., et al.
Publicado: (2021) -
MIS416 as a siRNA Delivery System with the Ability to Target Antigen-Presenting Cells
por: Mainini, Francesco, et al.
Publicado: (2018) -
Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling
por: Cheng, Demin, et al.
Publicado: (2021) -
Suppressing Sart1 to modulate macrophage polarization by siRNA-loaded liposomes: a promising therapeutic strategy for pulmonary fibrosis
por: Pan, Ting, et al.
Publicado: (2021)